TWI784258B - 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 - Google Patents

來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 Download PDF

Info

Publication number
TWI784258B
TWI784258B TW109112451A TW109112451A TWI784258B TW I784258 B TWI784258 B TW I784258B TW 109112451 A TW109112451 A TW 109112451A TW 109112451 A TW109112451 A TW 109112451A TW I784258 B TWI784258 B TW I784258B
Authority
TW
Taiwan
Prior art keywords
methylation
plasma
dna
cancer
cell
Prior art date
Application number
TW109112451A
Other languages
English (en)
Chinese (zh)
Other versions
TW202043483A (zh
Inventor
煜明 盧
慧君 趙
君賜 陳
妙芬 倫
渭雯 陳
江培勇
Original Assignee
香港中文大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI784258(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by 香港中文大學 filed Critical 香港中文大學
Publication of TW202043483A publication Critical patent/TW202043483A/zh
Application granted granted Critical
Publication of TWI784258B publication Critical patent/TWI784258B/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
TW109112451A 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 TWI784258B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US61/703,512 2012-09-20
US13/842,209 2013-03-15
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
US61/830,571 2013-06-03

Publications (2)

Publication Number Publication Date
TW202043483A TW202043483A (zh) 2020-12-01
TWI784258B true TWI784258B (zh) 2022-11-21

Family

ID=50340462

Family Applications (6)

Application Number Title Priority Date Filing Date
TW109112451A TWI784258B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW112118074A TWI901957B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW102134227A TWI640634B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TW111119079A TWI806621B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW114135706A TW202605158A (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW107123815A TWI707953B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Family Applications After (5)

Application Number Title Priority Date Filing Date
TW112118074A TWI901957B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW102134227A TWI640634B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TW111119079A TWI806621B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW114135706A TW202605158A (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
TW107123815A TWI707953B (zh) 2012-09-20 2013-09-23 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Country Status (28)

Country Link
EP (6) EP3536807B1 (cg-RX-API-DMAC10.html)
JP (6) JP6317354B2 (cg-RX-API-DMAC10.html)
KR (5) KR102307424B1 (cg-RX-API-DMAC10.html)
CN (2) CN117757932A (cg-RX-API-DMAC10.html)
AU (5) AU2013317708C1 (cg-RX-API-DMAC10.html)
BR (3) BR122021021823B1 (cg-RX-API-DMAC10.html)
CA (2) CA2884066C (cg-RX-API-DMAC10.html)
CY (1) CY1124139T1 (cg-RX-API-DMAC10.html)
DK (4) DK4056712T3 (cg-RX-API-DMAC10.html)
EA (1) EA201500327A1 (cg-RX-API-DMAC10.html)
ES (5) ES3060911T3 (cg-RX-API-DMAC10.html)
FI (2) FI3536807T3 (cg-RX-API-DMAC10.html)
HR (3) HRP20240210T1 (cg-RX-API-DMAC10.html)
HU (3) HUE053822T2 (cg-RX-API-DMAC10.html)
IL (4) IL313451A (cg-RX-API-DMAC10.html)
LT (2) LT3354747T (cg-RX-API-DMAC10.html)
MX (1) MX360034B (cg-RX-API-DMAC10.html)
MY (2) MY187444A (cg-RX-API-DMAC10.html)
NZ (2) NZ717423A (cg-RX-API-DMAC10.html)
PH (2) PH12022552061A1 (cg-RX-API-DMAC10.html)
PL (5) PL4056712T3 (cg-RX-API-DMAC10.html)
PT (4) PT4056712T (cg-RX-API-DMAC10.html)
SG (2) SG11201501927VA (cg-RX-API-DMAC10.html)
SI (1) SI4056712T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202100256T1 (cg-RX-API-DMAC10.html)
TW (6) TWI784258B (cg-RX-API-DMAC10.html)
WO (1) WO2014043763A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201501772B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI806621B (zh) * 2012-09-20 2023-06-21 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
US12518854B2 (en) 2012-09-20 2026-01-06 The Chinese University Of Hong Kong Non-invasive detection of tissue abnormality using methylation

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2685893T3 (es) * 2013-07-30 2018-10-15 Bgi Genomics Co., Limited Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
RU2717641C2 (ru) * 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
US10801067B2 (en) 2014-05-09 2020-10-13 Eurofins Lifecodexx Gmbh Detection of DNA that originates from a specific cell-type and related methods
TWI758011B (zh) 2014-07-18 2022-03-11 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
WO2016109452A1 (en) 2014-12-31 2016-07-07 Guardant Health , Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
DK3256605T3 (da) * 2015-02-10 2022-03-14 Univ Hong Kong Chinese Påvisning af mutationer til cancerscreening og føtal analyse
WO2017012544A1 (en) * 2015-07-20 2017-01-26 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
US10453556B2 (en) * 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
US11319586B2 (en) 2015-08-12 2022-05-03 The Chinese University Of Hong Kong Single-molecule sequencing of plasma DNA
MY199897A (en) 2015-09-22 2023-11-28 Univ Hong Kong Chinese Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP4180532A1 (en) * 2015-11-09 2023-05-17 Roche Molecular Systems, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
CA3168463A1 (en) * 2015-12-17 2017-06-22 Illumina, Inc. Distinguishing methylation levels in complex biological samples
EP4779643A2 (en) * 2016-02-02 2026-07-22 Guardant Health, Inc. Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2017181146A1 (en) * 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
US11078475B2 (en) 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
CA3023335A1 (en) * 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
CN115161390B (zh) 2016-05-30 2025-12-05 香港中文大学 使用血液中的无细胞dna检测血液病症
WO2017218908A2 (en) * 2016-06-16 2017-12-21 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) * 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
EP4209598A1 (en) 2016-10-19 2023-07-12 The Chinese University of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
TWI797095B (zh) 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統
IL266347B2 (en) * 2016-11-30 2025-01-01 Univ Hong Kong Chinese Analysis of cell-free DNA in urine and other samples
US20190309374A1 (en) * 2016-12-13 2019-10-10 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
MX2019008320A (es) * 2017-01-11 2019-09-09 Quest Diagnostics Invest Llc Metodo para la deteccion prenatal no invasiva de aneuploidia.
ES2981092T3 (es) * 2017-01-24 2024-10-07 Bgi Genomics Co Ltd Procedimiento para determinar la proporción de ácidos nucleicos acelulares procedentes de una fuente predeterminada en una muestra biológica
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CN111417731A (zh) * 2017-05-12 2020-07-14 哈佛学院校长同事会 通用早期癌症诊断
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
CA3069668A1 (en) * 2017-07-12 2019-01-17 Ande Corporation Pattern recognition system
KR102628878B1 (ko) * 2017-07-12 2024-01-23 유니버시티 헬스 네트워크 메틸롬 분석을 이용한 암 검출 및 분류
WO2019020057A1 (en) 2017-07-26 2019-01-31 The Chinese University Of Hong Kong ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
WO2019067973A1 (en) 2017-09-28 2019-04-04 Grail, Inc. ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES
US11168356B2 (en) 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
AU2019233897B2 (en) * 2018-03-15 2024-10-24 Grail, Inc. Tissue-specific methylation marker
CA3302676A1 (en) 2018-04-02 2026-05-13 Grail, Inc. Methylation markers and targeted methylation probe panels
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
CN121137125A (zh) * 2018-04-16 2025-12-16 格里尔公司 用于确定在无细胞核酸中的肿瘤分数的系统及方法
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
AU2019384154B2 (en) 2018-11-21 2025-11-20 Agilent Technologies, Inc. Methods for targeted nucleic acid library formation
CN113366122B (zh) * 2018-12-19 2024-01-12 香港中文大学 游离dna末端特征
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
ES2994567T3 (en) 2019-02-05 2025-01-27 Grail Inc Detecting cancer, cancer tissue of origin, and/or a cancer cell type
TWI874374B (zh) 2019-03-25 2025-03-01 香港中文大學 確定循環核酸之線性及環狀形式
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
AU2020268885B2 (en) * 2019-05-03 2026-06-11 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
JP7859967B2 (ja) * 2019-08-19 2026-05-15 グリーン クロス ゲノム コーポレーション 核酸断片間距離情報を用いた染色体異常検出方法
EP3795685A1 (en) 2019-09-20 2021-03-24 Sophia Genetics S.A. Methods for dna library generation to facilitate the detection and reporting of low frequency variants
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
WO2021108654A1 (en) * 2019-11-27 2021-06-03 Grail, Inc. Systems and methods for evaluating longitudinal biological feature data
CN115103909A (zh) 2020-01-31 2022-09-23 艾维达生物医学公司 用于靶向核酸捕获的系统和方法
CN115398007A (zh) * 2020-02-10 2022-11-25 帕洛根公司 纳米孔装置和使用其检测和分类带电粒子的方法
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
WO2021174072A1 (en) * 2020-02-28 2021-09-02 Grail, Inc. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
AU2021384324A1 (en) * 2020-11-19 2023-06-22 Nucleix Ltd. Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing
WO2022133315A1 (en) * 2020-12-17 2022-06-23 President And Fellows Of Harvard College Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
CN118302816A (zh) * 2021-09-28 2024-07-05 行动基因(智财)有限公司 甲基化生物标记选择装置及方法
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
CN118215743A (zh) * 2021-11-04 2024-06-18 通用诊断股份公司 用于制备用于基因测序的生物样品的系统和方法
GB2636509B (en) 2022-02-07 2026-02-18 Centre For Novostics Fragmentation for measuring methylation and disease
US20240150840A1 (en) * 2022-02-22 2024-05-09 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
EP4623107A4 (en) * 2022-11-23 2026-03-11 Found Medicine Inc CUSTOMIZED METHYLATION BIOMARKER MONITORING SYSTEMS AND METHODS FOR DISEASE DETECTION
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038507A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
TWI640634B (zh) * 2012-09-20 2018-11-11 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
DK1342794T3 (da) † 2002-03-05 2006-04-24 Epigenomics Ag Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
EP1570081A4 (en) * 2002-11-19 2006-05-31 Amgen Inc AMPLIFIED GENES INVOLVED IN CANCER
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP2380993B1 (en) 2004-03-08 2015-12-23 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
WO2006128192A2 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
US12054776B2 (en) 2007-07-23 2024-08-06 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
LT3241914T (lt) * 2009-11-05 2019-04-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
CA2780016C (en) 2009-11-06 2017-09-19 The Chinese University Of Hong Kong Size-based genomic analysis
AU2011207544A1 (en) * 2010-01-19 2012-09-06 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
EP2529032B1 (en) † 2010-01-26 2017-01-25 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
JP6073217B2 (ja) † 2010-04-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ゲノムモデルに関するデータ統合を用いたパスウェイ認識アルゴリズム（ｐａｒａｄｉｇｍ）
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
ES2581594T3 (es) 2010-05-25 2016-09-06 The Johns Hopkins University Composiciones y métodos para detectar una neoplasia
SG10201505723UA (en) * 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
EP2596127A2 (en) * 2010-07-23 2013-05-29 Esoterix Genetic Laboratories, LLC Identification of differentially represented fetal or maternal genomic regions and uses thereof
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
KR102040307B1 (ko) † 2010-11-30 2019-11-27 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038507A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
TWI640634B (zh) * 2012-09-20 2018-11-11 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組（ｍｅｔｈｙｌｏｍｅ）之非侵入性測定
TWI707953B (zh) * 2012-09-20 2020-10-21 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI806621B (zh) * 2012-09-20 2023-06-21 香港中文大學 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
US12518854B2 (en) 2012-09-20 2026-01-06 The Chinese University Of Hong Kong Non-invasive detection of tissue abnormality using methylation

Also Published As

Publication number Publication date
TWI707953B (zh) 2020-10-21
JP6985753B2 (ja) 2021-12-22
IL237495B (en) 2019-09-26
HUE068129T2 (hu) 2024-12-28
NZ706269A (en) 2016-08-26
EP2898100A1 (en) 2015-07-29
ES2994426T3 (en) 2025-01-23
EP3354747B1 (en) 2021-02-17
ES2969567T3 (es) 2024-05-21
JP2022031753A (ja) 2022-02-22
IL299444B2 (en) 2024-11-01
PL2898100T5 (pl) 2023-11-06
TWI640634B (zh) 2018-11-11
JP2024009833A (ja) 2024-01-23
EP3536807B1 (en) 2023-11-29
SG10201705198UA (en) 2017-07-28
CN104781422A (zh) 2015-07-15
KR102307424B1 (ko) 2021-09-29
JP7594817B2 (ja) 2024-12-05
IL268512A (en) 2019-09-26
ES2862726T3 (es) 2021-10-07
CN104781422B (zh) 2023-12-26
IL299444A (en) 2023-02-01
EP4056712A1 (en) 2022-09-14
LT4056712T (lt) 2024-09-10
PL3536807T3 (pl) 2024-05-06
AU2013317708A1 (en) 2015-04-09
DK4056712T3 (da) 2024-08-26
HRP20241142T1 (hr) 2024-11-22
TWI806621B (zh) 2023-06-21
JP2015536639A (ja) 2015-12-24
CA2884066C (en) 2021-08-10
PL2898100T3 (pl) 2018-06-29
IL237495A0 (en) 2015-04-30
EA201500327A1 (ru) 2015-07-30
KR102148547B1 (ko) 2020-08-26
KR20230145530A (ko) 2023-10-17
HRP20240210T1 (hr) 2024-05-10
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
ES2665273T3 (es) 2018-04-25
EP4335929A3 (en) 2024-05-29
LT3354747T (lt) 2021-04-12
DK3354747T3 (da) 2021-04-19
KR20150082228A (ko) 2015-07-15
SG11201501927VA (en) 2015-04-29
CA2884066A1 (en) 2014-03-27
BR112015006183A2 (pt) 2017-07-04
CN117757932A (zh) 2024-03-26
JP2025026936A (ja) 2025-02-26
AU2017251832A1 (en) 2017-11-16
BR112015006183B1 (pt) 2022-04-26
CY1124139T1 (el) 2022-05-27
PH12015500547B1 (en) 2024-05-17
PL4056712T3 (pl) 2024-12-02
EP3839065A1 (en) 2021-06-23
TW201418474A (zh) 2014-05-16
AU2022201026A1 (en) 2022-03-10
TW202305145A (zh) 2023-02-01
ES3060911T3 (en) 2026-03-30
ZA201501772B (en) 2016-10-26
PL3354747T3 (pl) 2021-07-26
NZ717423A (en) 2017-08-25
WO2014043763A1 (en) 2014-03-27
KR20210120124A (ko) 2021-10-06
EP2898100B1 (en) 2017-11-22
KR102587176B1 (ko) 2023-10-06
EP2898100B2 (en) 2023-05-10
HK1257868A1 (en) 2019-11-01
JP2018121644A (ja) 2018-08-09
AU2025205087A1 (en) 2025-07-24
EP3354747A1 (en) 2018-08-01
HK1206797A1 (en) 2016-01-15
KR20200085928A (ko) 2020-07-15
EP2898100A4 (en) 2016-05-11
CA3122779A1 (en) 2014-03-27
DK2898100T3 (en) 2018-02-26
SI4056712T1 (sl) 2024-10-30
AU2013317708C1 (en) 2017-11-23
JP6683752B2 (ja) 2020-04-22
TWI901957B (zh) 2025-10-21
MX360034B (es) 2018-10-19
EP4335929B1 (en) 2026-01-21
FI3536807T3 (fi) 2024-02-01
MX2015003571A (es) 2015-06-22
AU2013317708B2 (en) 2017-08-03
PH12015500547A1 (en) 2015-05-04
PT3536807T (pt) 2024-02-01
TW202043483A (zh) 2020-12-01
DK2898100T4 (da) 2023-07-24
SMT202100256T1 (it) 2021-05-07
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
FI4056712T3 (fi) 2024-08-29
EP4335929A2 (en) 2024-03-13
JP6317354B2 (ja) 2018-04-25
EP4056712B1 (en) 2024-07-31
AU2017251832B2 (en) 2019-10-10
EP4335929C0 (en) 2026-01-21
ES2665273T5 (es) 2023-10-02
EP2898100B9 (en) 2023-08-02
AU2022201026B2 (en) 2025-04-03
TW202334438A (zh) 2023-09-01
MY187444A (en) 2021-09-22
AU2020200128A1 (en) 2020-01-30
JP2020108400A (ja) 2020-07-16
HUE053822T2 (hu) 2021-07-28
PT2898100T (pt) 2018-02-26
DK3536807T3 (da) 2024-02-05
TW201907013A (zh) 2019-02-16
KR20220065034A (ko) 2022-05-19
BR122021021823B1 (pt) 2023-04-25
HRP20210716T1 (hr) 2021-06-11
BR122021021825B1 (pt) 2022-05-24
HK1207124A1 (en) 2016-01-22
MY173356A (en) 2020-01-21
PL4335929T3 (pl) 2026-04-07
IL313451A (en) 2024-08-01
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
TW202605158A (zh) 2026-02-01
HUE066054T2 (hu) 2024-07-28
AU2020200128B2 (en) 2021-11-18
IL268512B2 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
JP7594817B2 (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
US20250349386A1 (en) Non-invasive detection of tissue abnormality using methylation
HK40013800B (en) Non-invasive determination of methylome of tumor from plasma
HK40013800A (en) Non-invasive determination of methylome of tumor from plasma
HK1257868B (en) Non-invasive determination of methylome of tumor from plasma
HK1207124B (en) Non-invasive determination of methylome of fetus or tumor from plasma
HK1206797B (en) Non-invasive determination of methylome of fetus or tumor from plasma